Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;61(2):181-6.
doi: 10.1016/j.diagmicrobio.2008.01.002. Epub 2008 Mar 4.

Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals

Affiliations

Evaluation of the diagnostic utility of a whole-blood interferon-gamma assay for determining the risk of exposure to Mycobacterium tuberculosis in Bacille Calmette-Guerin (BCG)-vaccinated individuals

Seok-Yong Eum et al. Diagn Microbiol Infect Dis. 2008 Jun.

Abstract

We evaluated the utility of the "QuantiFERON-TB Gold In-Tube" (QuantiFERON) test that uses tuberculosis (TB)-specific antigens for the diagnosis of latent infection in such individuals. We also examined the correlation between the interferon (IFN)-gamma response to these antigens and the exposure risk to TB by evaluating antigen-specific IFN-gamma release in comparison with IFN-gamma release in response to purified protein derivative (PPD) in 3 groups: medical students, nurses in a TB hospital, and TB patients. All nurses and TB patients responded to PPD, whereas 52% (P < 0.0001) and 79.2% (P = 0.04) responded to QuantiFERON, respectively. In the medical students, only 10.4% responded to QuantiFERON, whereas 85.2% were positive to PPD (P < 0.0001). There was also a significant correlation between the levels of IFN-gamma production and the duration of employment in the group of nurses at the TB hospital, suggesting ongoing exposure in this high-risk group. Thus, these results demonstrate that Mycobacterium tuberculosis-specific IFN-gamma release assay accurately discriminates low- and high-risk healthy subjects and might therefore be a useful diagnostic tool for the diagnosis of latent infection in Bacille Calmette-Guerin (BCG)-vaccinated individuals.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Whole blood response to PPD in different groups. Group A : Medical students (low risk); Group B : nurses at TB hospital (high risk); Group C : TB patients. Whole blood was stimulated with PPD for 5 days. IFN-γ release was determined by ELISA. Broken line shows the cut-off value for positive responders (62 pg/ml). Horizontal bars represent mean IFN-γ value. The significant difference of IFN-γ production levels was analyzed between two groups and P value less than 0.05 was considered significant. N.S. : not significant.
Figure 2
Figure 2
IFN-γ assay by “QuantiFERON®-TB Gold in tube” test in different groups. Group A : Medical students (low risk); Group B : nurses at TB hospital (high risk); Group C : TB patients. Whole blood were stimulated in a tube containing a mixture of ESAT-6, CFP-10, and a portion of TB antigen TB 7.7 for 20 h. IFN-γ release was determined by ELISA. Broken line shows the cut-off value for positive responders (0.35 IU/ml). Horizontal bars represent mean IFN-γ value. The significant differences of IFN-γ production levels were analyzed between two groups and P value less than 0.05 was considered significant. N.S. : not significant.
Figure 3
Figure 3
The correlation analysis in high risk individuals (Group B) between the exposure period to M. tuberculosis and the secretion levels of IFN-γ in response to PPD (A) or to a mixture of M. tuberculosis-specific antigens (B). Each point represents each individual value. A significant correlation (r = 0.424, p = 0.035) was found by M. tuberculosis-specific antigens. N.S. : not significant.

References

    1. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Pespir Crit Care Med. 2000;161:S221–S247. - PubMed
    1. Anderson P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356:1099–1104. - PubMed
    1. Arend SM, Anderson P, van Meijgaarden KE, Skjot RLV, Subronto YW, van Dissel JT, Ottenhoff THM. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis. 2000;181:1850–1854. - PubMed
    1. Aziz MA, Wright A. The World Health Organization/International Union Against Tuberculosis and Lung Disease Global Project on Surveillance for Anti-Tuberculosis Drug Resistance: a model for other infectious diseases. Clin Infect Dis. 2005;15:S258–S262. - PubMed
    1. Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, Blackwell JM, Bliss L, Sichali L, Mwaungulu L, Chaguluka S, Jarman E, Ngwira B, Dockrell HM. Relationship between IFN-γ and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Inter J Tuberc Lung Dis. 2001;5:664–672. - PubMed

Publication types

Substances